⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DFTX News
Definium Therapeutics, Inc. Common Shares
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
businesswire.com
DFTX
Definium Therapeutics to Participate at Upcoming Investor Conferences
businesswire.com
DFTX
Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
businesswire.com
DFTX
Definium Therapeutics Announces New Employee Inducement Grants
businesswire.com
DFTX
Definium Therapeutics Appoints Roger Adsett to Board of Directors
businesswire.com
DFTX
Definium Therapeutics Announces New Employee Inducement Grants
businesswire.com
DFTX
Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care
businesswire.com
DFTX
2026 Asset Growth: Why Federal Compliance Is the New Metric
globenewswire.com
CGC
DFTX
LPCN
KDP